AR101 oral immunotherapy effective in reducing severity of peanut allergy – Healio
Healio |
AR101 oral immunotherapy effective in reducing severity of peanut allergy
Healio “It is exciting to see this large-scale study confirm that a characterized approach to oral immunotherapy in an appropriately supervised clinical setting holds promise for becoming an approved treatment,” A. Wesley Burks, MD, executive dean and Curnen … Immunotherapy for peanut allergy safe, effective in clinical trial Peanut Allergy Oral Immunotherapy Effective in Phase 3 Study Peanut OIT Therapy Sees Success, Boosting Hope for FDA Approval |
